A comprehensive model to predict severe acute graft-versus-host disease in acute leukemia patients after haploidentical hematopoietic stem cell transplantation

A comprehensive model to predict severe acute graft-versus-host disease in acute leukemia patients after haploidentical hematopoietic stem cell transplantation

Abstract Background Acute graft-versus-host disease (aGVHD) remains the major cause of early mortality after haploidentical related donor (HID) hematopoietic stem cell transplantation (HSCT). We aimed to establish a comprehensive model which could predict severe aGVHD after HID HSCT. Methods Consecu...

Description complète

Détails bibliographiques
Auteurs principaux:	Meng-Zhu Shen, Shen-Da Hong, Rui Lou, Rui-Ze Chen, Xiao-Hui Zhang, Lan-Ping Xu, Yu Wang, Chen-Hua Yan, Huan Chen, Yu-Hong Chen, Wei Han, Feng-Rong Wang, Jing-Zhi Wang, Kai-Yan Liu, Xiao-Jun Huang, Xiao-Dong Mo
Format:	Article
Langue:	English
Publié:	BMC 2022-05-01
Collection:	Experimental Hematology & Oncology
Sujets:	Acute leukemia Acute graft-versus-host disease Haploidentical donor Hematopoietic stem cell transplant Predicted model
Accès en ligne:	https://doi.org/10.1186/s40164-022-00278-x

Documents similaires

Case report: First report of haploidentical allogeneic hematopoietic stem cell transplantation from donors with mild alpha-thalassemia for acute leukemia
par: Wenshuai Zheng, et autres
Publié: (2022-12-01)

Haploidentical Stem Cell Transplantation for Acute Myeloid Leukemia: Current Therapies, Challenges and Future Prospective
par: Ying-Jun Chang, et autres
Publié: (2021-10-01)

A Predicted Model for Refractory/Recurrent Cytomegalovirus Infection in Acute Leukemia Patients After Haploidentical Hematopoietic Stem Cell Transplantation
par: Meng-Zhu Shen, et autres
Publié: (2022-03-01)

Effectiveness of T-Cell Replete Haploidentical Hematopoietic Stem Cell Transplantation for Refractory/Relapsed B Cell Acute Lymphoblastic Leukemia in Children and Adolescents
par: Hideki Sano, et autres
Publié: (2021-10-01)

Unrelated umbilical cord blood can improve the prognosis of haploidentical hematopoietic stem cell transplantation
par: Ying Yang, et autres
Publié: (2022-09-01)

Unmanipulated haploidentical hematopoietic stem cell transplantation for pediatric de novo acute megakaryoblastic leukemia without Down syndrome in China: A single-center study
par: Junbin Huang, et autres
Publié: (2023-02-01)

Immune Reconstitution of Patients Who Recovered From Steroid-Refractory Acute Graft-Versus-Host Disease After Basiliximab Treatment
par: Dao-Xing Deng, et autres
Publié: (2022-07-01)

Haploidentical donor is preferred over matched sibling donor for pre-transplantation MRD positive ALL: a phase 3 genetically randomized study
par: Ying-Jun Chang, et autres
Publié: (2020-03-01)

Successful Treatment of Severe Steroid-Resistant Engraftment Syndrome Following Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia with Emapalumab: A Case Report
par: Tian Z, et autres
Publié: (2024-06-01)

Successful Haploidentical Hematopoietic Stem Cell Transplantation with Azacitidine and Venetoclax Maintenance Therapy for Acute Myeloid Leukemia with NUP98-RARG Gene Fusion
par: Jiaojiao Yuan, et autres
Publié: (2023-03-01)

Haploidentical related donor vs matched sibling donor allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome aged over 50 years: A single‐center retrospective study
par: Jiafu Huang, et autres
Publié: (2020-09-01)

Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
par: Arnon Nagler, et autres
Publié: (2021-04-01)

Human leukocyte antigen evolutionary divergence as a novel risk factor for donor selection in acute lymphoblastic leukemia patients undergoing haploidentical hematopoietic stem cell transplantation
par: Xing-Yu Cao, et autres
Publié: (2024-08-01)

Intensified conditioning regimen with fludarabine combined with post-transplantation cyclophosphamide for haploidentical allogeneic hematopoietic stem cell transplantation in children with high-risk acute leukemia
par: Junjie Cao, et autres
Publié: (2023-12-01)

Efficacy and safety of prophylactic modified donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia
par: YANG Luxin, et autres
Publié: (2019-12-01)

The Incidence, Outcomes, and Risk Factors of Secondary Poor Graft Function in Haploidentical Hematopoietic Stem Cell Transplantation for Acquired Aplastic Anemia
par: Fan Lin, et autres
Publié: (2022-05-01)

Future directions in haploidentical hematopoietic stem cell transplantation
par: Pongthep Vittayawacharin, et autres
Publié: (2024-12-01)

G-CSF-Primed Peripheral Blood Stem Cell Haploidentical Transplantation Could Achieve Satisfactory Clinical Outcomes for Acute Leukemia Patients in the First Complete Remission: A Registered Study
par: Yan-Ru Ma, et autres
Publié: (2021-03-01)

Haploidentical vs. HLA-matched donor hematopoietic stem-cell transplantation for pediatric patients with acute lymphoblastic leukemia in second remission: A collaborative retrospective study of the Spanish Group for Bone Marrow Transplantation in Children (GETMON/GETH) and the Spanish Childhood Relapsed ALL Board (ReALLNet)
par: Celia Moreno, et autres
Publié: (2023-03-01)

Haploidentical hematopoietic stem cell transplantation in a myelofibrosis patient with primary graft failure
par: Cristina Tecchio, et autres
Publié: (2018-01-01)

Two dose levels of rabbit antithymocyte globulin as graft-versus-host disease prophylaxis in haploidentical stem cell transplantation: a multicenter randomized study
par: Ren Lin, et autres
Publié: (2019-08-01)

The history of haploidentical stem cell transplantation: a trip from the bench to the bedside
par: Mariana G. Meade, et autres
Publié: (2024-12-01)

Commentary: Post-Transplantation Cyclophosphamide Uniquely Restrains Alloreactive CD4+ T-Cell Proliferation and Differentiation After Murine MHC-Haploidentical Hematopoietic Cell Transplantation
par: Jessica Stokes, et autres
Publié: (2022-04-01)

Can doses of post-transplantation cyclophosphamide in haploidentical stem cell allografts be reduced?
par: Juan Carlos Olivares-Gazca, et autres
Publié: (2023-12-01)

Case report: Donor lymphocyte infusion and blinatumomab as treatment for acute lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation
par: Flavia Antonucci, et autres
Publié: (2024-03-01)

Effects of anti-HLA donor-specific antibodies and desensitization on engraftment of haploidentical hematopoietic stem cell transplantation
par: MA Yao, et autres
Publié: (2024-02-01)

Risk factors and clinical outcomes of cytomegalovirus infection following haploidentical hematopoietic stem cell transplantation in patients with aplastic anemia: a single-center retrospective study
par: Jia Feng, et autres
Publié: (2025-01-01)

Haploidentical stem cell transplant: Established treatment, expanding horizons
par: Mukul Aggarwal, et autres
Publié: (2016-01-01)

Umbilical cord blood stem cells as third-party adjuvant infusions in human leukocyte antigen antibody-positive patients undergoing haploidentical hematopoietic stem cell transplantation
par: Yuying Wang, et autres
Publié: (2024-09-01)

Key Aspects of the Immunobiology of Haploidentical Hematopoietic Cell Transplantation
par: Susanne H. C. Baumeister, et autres
Publié: (2020-02-01)

Influence of ABO compatibility on haploidentical hematopoietic stem-cell transplant
par: Rajesh B Sawant, et autres
Publié: (2023-01-01)

Desensitization with plasma exchange in a patient with human leukocyte antigen donor-specific antibodies before T-cell-replete haploidentical hematopoietic stem cell transplantation
par: Rasika Dhawan Setia, et autres
Publié: (2019-01-01)

Minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplant
par: Chen-Hua Yan, et autres
Publié: (2016-09-01)

Similar outcomes following non-first-degree and first-degree related donor haploidentical hematopoietic cell transplantation for acute leukemia patients in complete remission: a study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
par: Yishan Ye, et autres
Publié: (2023-03-01)

Clinical evaluation of haploidentical hematopoietic combined with human umbilical cord-derived mesenchymal stem cells in severe aplastic anemia
par: Lixin Xu, et autres
Publié: (2018-03-01)

Comparisons of Long-Term Survival and Safety of Haploidentical Hematopoietic Stem Cell Transplantation After CAR-T Cell Therapy or Chemotherapy in Pediatric Patients With First Relapse of B-Cell Acute Lymphoblastic Leukemia Based on MRD-Guided Treatment
par: Guanhua Hu, et autres
Publié: (2022-06-01)

Hematopoietic Stem Cell Transplantation—50 Years of Evolution and Future Perspectives
par: Israel Henig, et autres
Publié: (2014-10-01)

Identification of Heme Oxygenase-1 as a Novel Predictor of Hematopoietic Stem Cell Transplantation Outcomes in Acute Leukemia
par: Yinghao Lu, et autres
Publié: (2016-09-01)

Efficacy and Safety of Unmanipulated Haploidentical Related Donor Allogeneic Peripheral Blood Stem Cell Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia
par: Li-Ping Dou, et autres
Publié: (2018-01-01)

Who is the best haploidentical donor for acquired severe aplastic anemia? Experience from a multicenter study
par: Lan-Ping Xu, et autres
Publié: (2019-09-01)